Barbara Levi
General Counsel at UBS GROUP AG
Net worth: 1 M $ as of 2024-03-30
Profile
Barbara Levi is currently the Director at the European General Counsel Association.
She also holds the position of Group General Counsel at UBS AG and UBS Group AG.
Additionally, she serves as a Member-Employees Board at King's College London.
Previously, she worked as the Group General Counsel at Rio Tinto Plc and Chief Legal, Governance & Ethics Officer at Rio Tinto Ltd.
Prior to that, she was the Global General Counsel at Sandoz International GmbH and Global Legal Head-Product Strategy at Novartis Pharma AG.
Ms. Levi holds a graduate degree from the University of Milan and a graduate degree from Fordham University School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
UBS GROUP AG
0.00% | 2022-12-30 | 45,818 ( 0.00% ) | 1 M $ | 2024-03-30 |
Barbara Levi active positions
| Companies | Position | Start |
|---|---|---|
| UBS GROUP AG | General Counsel | 2021-10-31 |
| UBS | General Counsel | 2021-10-31 |
| European General Counsel Association | Director/Board Member | - |
| King's College London | Corporate Officer/Principal | - |
Former positions of Barbara Levi
| Companies | Position | End |
|---|---|---|
| RIO TINTO PLC | Public Communications Contact | 2021-10-24 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | General Counsel | 2018-12-31 |
| RIO TINTO GROUP | Public Communications Contact | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | General Counsel | 2012-12-31 |
Training of Barbara Levi
| University of Milan | Graduate Degree |
| Fordham University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| RIO TINTO PLC | Non-Energy Minerals |
| UBS GROUP AG | Finance |
| RIO TINTO GROUP | Non-Energy Minerals |
| Private companies | 4 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
| European General Counsel Association |
- Stock Market
- Insiders
- Barbara Levi
